These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8436563)

  • 1. In vivo antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
    Mine Y; Watanabe Y; Sakamoto H; Hatano K; Wakai Y; Kamimura T; Tawara S; Matsumoto S; Matsumoto F; Kuwahara S
    J Antibiot (Tokyo); 1993 Jan; 46(1):88-98. PubMed ID: 8436563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci.
    Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Kamimura T; Tawara S; Matsumoto Y; Matsumoto F; Kuwahara S
    J Antibiot (Tokyo); 1993 Jan; 46(1):99-119. PubMed ID: 8436564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
    Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Higashi Y; Kamimura T; Matsumoto Y; Tawara S; Matsumoto F
    J Antibiot (Tokyo); 1993 Jan; 46(1):71-87. PubMed ID: 8436562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
    Nishino T; Otsuki M; Hatano K; Nishihara Y
    Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo antibacterial activities of FK037, a novel parenteral broad-spectrum cephalosporin.
    Fu KP; Foleno BD; Lafredo SC; LoCoco JM; Isaacson DM
    Antimicrob Agents Chemother; 1993 Feb; 37(2):301-7. PubMed ID: 8452361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antibacterial activities of FK037: a new parenteral cephalosporin.
    Inoue K; Inoue E; Mitsuhashi S
    Chemotherapy; 1995; 41(4):257-66. PubMed ID: 7555206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp.
    Baltch AL; Smith RP; Ritz W
    Chemotherapy; 1994; 40(6):391-8. PubMed ID: 7842822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antibacterial activity of FK037, a new parenteral broad-spectrum cephalosporin, against recent clinical isolates in the fields of obstetrics and gynecology.
    Mikamo H; Izumi K; Ito K; Katoh N; Watanabe K; Ueno K; Tamaya T
    Chemotherapy; 1994; 40(3):161-6. PubMed ID: 8205934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin.
    Toyosawa T; Miyazaki S; Tsuji A; Yamaguchi K; Goto S
    Antimicrob Agents Chemother; 1993 Jan; 37(1):60-6. PubMed ID: 8431019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro activity of FK 037 (Cefoselis), a novel 4(th) generation cephalosporin, compared to cefepime and cefpirome on nosocomial staphylococci and gram-negative isolates.
    Giamarellos-Bourboulis EJ; Grecka P; Tsitsika A; Tympanidou C; Giamarellou H
    Diagn Microbiol Infect Dis; 2000 Mar; 36(3):185-91. PubMed ID: 10729661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin with a broad antibacterial spectrum.
    Hata K; Otsuki M; Nishino T
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1894-901. PubMed ID: 1416879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of cefpirome, a new cephalosporin, on various models of infections in mice and rats.
    Arai S; Kobayashi S; Hayashi S
    Jpn J Antibiot; 1990 Jan; 43(1):1-8. PubMed ID: 2190011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
    Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA
    Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The post-antibiotic effect of antimicrobial combinations in a neutropenic murine thigh infection model.
    Gudmundsson S; Einarsson S; Erlendsdottir H; Moffat J; Bayer W; Craig WA
    J Antimicrob Chemother; 1993 May; 31 Suppl D():177-91. PubMed ID: 8335520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CP6679, a new injectable cephalosporin with broad spectrum and potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
    Ida T; Tsushima M; Ishii T; Atsumi K; Tamura A
    J Infect Chemother; 2002 Jun; 8(2):138-44. PubMed ID: 12111566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of FK037, a new parenteral cephalosporin, against anaerobic bacteria.
    Kato N; Kato H; Tanaka Y; Bando K; Watanabe K; Ueno K
    Antimicrob Agents Chemother; 1993 May; 37(5):957-61. PubMed ID: 8517721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosa.
    Neu HC; Chin NX; Labthavikul P
    Infection; 1985; 13(3):146-55. PubMed ID: 3928497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo antibacterial activity of the new semisynthetic cephalosporin cefpirome.
    Mitsukude M; Inoue M; Mitsuhashi S
    Arzneimittelforschung; 1989 Jan; 39(1):26-30. PubMed ID: 2785801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo antibacterial activity of S-3578, a new broad-spectrum cephalosporin: methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa experimental infection models.
    Tsuji M; Takema M; Miwa H; Shimada J; Kuwahara S
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2507-12. PubMed ID: 12878512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.